Home » Topics » Conferences

Conferences
RSS

Significant research efforts center on new ketolide at Hoechst Marion Roussel

Oct. 9, 1997

Novel amphotericin B formulation reported by Japanese academics

Oct. 8, 1997

SB-207499: a second-generation PDE IV inhibitor from SmithKline Beecham

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Synthesis and biological evaluation reported for quinolonyl-carbacephems

Oct. 7, 1997

Abbott presents new ketolides based on TE-802

Oct. 7, 1997

P&G presents new quinolonyl-lactams

Oct. 7, 1997

Abbott describes synthesis and evaluation of novel erythromycin derivatives

Oct. 7, 1997

Abbott prepares and evaluates tetracyclic ketolides as antibacterials

Oct. 6, 1997

New antifungal antibiotic with sphingosine-like lipid moiety

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...